Anesthetic management of a patient with Kasabach-Merritt syndrome: A case report.
- Author:
Sung Chun PARK
1
;
Ji Young YOON
;
Jung Min HONG
;
Ji Uk YOON
;
Gyeong Jo BYEON
Author Information
1. Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, Korea. dryoonji@pusan.ac.kr
- Publication Type:Case Report
- Keywords:
Anesthetic management;
Kasabach-Merritt syndrome;
Thrombocytopenia
- MeSH:
Amputation;
Androstanols;
Anesthesia;
Bronchoscopes;
Fentanyl;
Frontal Lobe;
Hemangioma;
Hemorrhage;
Humans;
Infant, Newborn;
Interferon-alpha;
Kasabach-Merritt Syndrome;
Leg;
Male;
Methyl Ethers;
Platelet Count;
Platelet Transfusion;
Sclerotherapy;
Seizures;
Thiopental;
Thrombocytopenia;
Vincristine
- From:Anesthesia and Pain Medicine
2010;5(3):260-263
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Kasabach-Merritt syndrome presents various problems for anesthetic management, which include thrombocytopenia, bleeding tendency, and problems arising from the hemangioma mass itself. A 1-month-old male was given sclerotherapies, platelet transfusions, steroid, interferon alpha, vincristine because of the bleeding from the right lower leg hemangioma, but platelet numbers were decreased and seizures occurred due to frontal lobe focal hemorrhage. After all, he was scheduled for his right lower leg amputation when he was 7 months old. Anesthesia was carefully induced with thiopental, rocuronium, fentanyl, and flexible bronchoscope. It was maintained with sevoflurane and air/oxygen with fentanyl injection. Although excessive bleeding was expected during anesthesia and surgery, the operation was performed without correction of platelet number. Two days later, postoperative course was improved almost normal.
